Impact of D2 Lymphadenectomy on Morbidity and Long-Term Survival in Patients with Gastric Cancer

1997 ◽  
Vol 20 (2) ◽  
pp. 145-150 ◽  
Author(s):  
W.F.A. Hiller ◽  
J. Jähne ◽  
H.-J. Meyer
Keyword(s):  
Gastric Cancer ◽  
D2 Lymphadenectomy ◽  
Term Survival ◽  
Long Term Survival

scholarly journals Impact of the introduction of formal D2 lymphadenectomy for gastric cancer in a Western setting

2021 ◽  
Vol 64 (2) ◽  
Author(s):  
Alexandre Brind’Amour ◽  
Jean-Pierre Gagné ◽  
Jean-Charles Hogue ◽  
Éric Poirier
Keyword(s):  
Gastric Cancer ◽  
Lymph Nodes ◽  
Gastric Resection ◽  
Training Group ◽  
Technical Training ◽  
Perioperative Outcomes ◽  
D2 Lymphadenectomy ◽  
Term Survival ◽  
Long Term Survival

Background: Two members from an academic tertiary hospital went to the National Cancer Institute in Tokyo, Japan, to learn how to perform an adequate D2 lymphadenectomy and to then introduce this technique in the surgical care of patients undergoing surgery for gastric cancer at a Western hospital. We aimed to compare the perioperative outcomes and long-term survival of Western patients who underwent gastric resection, performed by these 2 surgeons, before and after the surgeons’ shortcourse technical training in Japan. Methods: We conducted a retrospective comparative study of all patients (n = 27 before training and n = 79 after training) who underwent gastric resection for cancer by the same 2 surgeons between September 2007 and December 2017 at the Centre Hospitalier Universitaire de Québec — Université Laval (Québec, Canada). We collected data on patient demographic, clinical, surgical, pathological and treatment characteristics, as well as long-term survival and complications. Results: In the post-training group, the number of sampled lymph nodes was higher (median 33 v. 14, p < 0.0001), but this increase did not result in a higher number of histologically positive lymph nodes (p = 0.35). The rate of complications was lower in the post-training group (15.2% v. 48.2%, p = 0.002). The hospital stay was shorter in the post-training group (11 [standard deviation (SD) 7] v. 23 [SD 45] d, p = 0.03). The median survival was higher in the post-training group (47 v. 29 mo, p = 0.03). Conclusion: These results suggest that a short-course technical training in D2 lymphadenectomy, completed in Japan, improved lymph node sampling, decreased postoperative complications and improved survival of patients undergoing surgery for gastric cancer in a Western setting.

scholarly journals Long-term survival differences in gastric cancer after D2 lymphadenectomy and an improved assessment of resectability

2017 ◽  
Vol 2 (1) ◽  
pp. 19-26
Author(s):  
Gabriel Dimofte ◽  
Silviu T. Makkai – Popa ◽  
Vlad Porumb ◽  
Simona Nicolescu ◽  
Sorinel Lunca
Keyword(s):  
Gastric Cancer ◽  
D2 Lymphadenectomy ◽  
Term Survival ◽  
Long Term Survival ◽  
Survival Differences

scholarly journals Long-Term Survival of Two Patients with Liver Metastases from Advanced Gastric Cancer Treated with Radiofrequency Ablation and Chemotherapy

2021 ◽  
pp. 67-72
Author(s):  
Sung Jin Oh
Keyword(s):  
Gastric Cancer ◽  
Radiofrequency Ablation ◽  
Liver Metastases ◽  
Advanced Gastric Cancer ◽  
Systemic Chemotherapy ◽  
Subtotal Gastrectomy ◽  
Hepatic Metastases ◽  
Term Survival ◽  
Long Term Survival

Liver metastasis from gastric cancer has a very poor prognosis. Herein, we present two cases of liver metastases (synchronous and metachronous) from advanced gastric cancer. In the first case, the patient underwent radical subtotal gastrectomy. Liver metastases occurred 6 months after surgery while the patient was receiving adjuvant chemotherapy, but two hepatic tumors were successfully removed by radiofrequency ablation (RFA). In the second case, liver metastases occurred 15 months after surgery for gastric cancer. The patient also received RFA for one hepatic tumor, and other suspicious metastatic tumors were treated with systemic chemotherapy. Although these case presentations are limited for the efficacy of RFA treatment with systemic chemotherapy for hepatic metastases from gastric cancer, our findings showed long-term survival (overall survival for 108 and 67 months, respectively) of the affected patients, without recurrence. Therefore, we suggest that RFA treatment with systemic chemotherapy could be an effective alternative treatment modality for hepatic metastases from gastric cancer.

scholarly journals Factors Affecting Long Term Survival for Metastatic Gastric Cancer Treated with Chemotherapy

2016 ◽  
Vol 16 (2) ◽  
pp. 97
Author(s):  
Seong Kyeong Lim ◽  
Kyoungwon Jung ◽  
Moo In Park ◽  
Jae Hyun Kim ◽  
Sung Eun Kim ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Metastatic Gastric Cancer ◽  
Term Survival ◽  
Long Term Survival ◽  
Factors Affecting
Sign in / Sign up

Export Citation Format

Share Document